<DOC>
	<DOCNO>NCT00943735</DOCNO>
	<brief_summary>The primary objective study assess level medication adherence observe among subject receive specific combination education support material ( YourWay plan ) along prescription fesoterodine .</brief_summary>
	<brief_title>This Is An Open-Label Study To Evaluate Fesoterodine Plus `` Your Way '' Patient Support Plan In Patients With Symptoms Of Overactive Bladder</brief_title>
	<detailed_description>This non-interventional , observational study . Study investigator recruit symptomatic , fesoterodine-naïve subject present OAB symptom regularly-scheduled physician visit fesoterodine-naïve subject OAB symptom present regularly-scheduled physician visit</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Male female outpatient &gt; =18 year old Eligible receive Toviaz 4mg 8mg QD treatment base approve US label . Female subject pregnant , lactating , intend become pregnant within 28 day completion study ( use contraceptive require participate study ) Have participate study involve study drug within 30 day prior entry study Subjects previously take fesoterodine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Overactive Bladder Incontinence Adherence Behavioral intervention</keyword>
</DOC>